bezafibrate has been researched along with platinum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ding, XJ; Gao, WZ; Gao, YY; Hu, JJ; Qiao, X; Xu, JY; Xu, LW; Zheng, LX | 1 |
1 other study(ies) available for bezafibrate and platinum
Article | Year |
---|---|
Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
Topics: AMP-Activated Protein Kinases; Apoptosis; Bezafibrate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA Damage; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Hypolipidemic Agents; Membrane Potential, Mitochondrial; Oxidative Stress; Platinum; Prodrugs; Reactive Oxygen Species; Signal Transduction | 2021 |